EXHIBIT 11 CYTOCLONAL PHARMACEUTICS INC. COMPUTATION OF NET (LOSS) PER COMMON SHARE (unaudited) THREE MONTHS NINE MONTHS ENDED SEPTEMBER 30, ENDED SEPTEMBER 30, 1996 1997 1996 1997 ----------- ------------ ------------ ------------ Net (loss) $ (808,000) $ (945,000) $(2,128,000) $(2,462,000) Add cumulative preferred dividend (79,000) (69,000) (238,000) (207,000) ---------- ----------- ----------- ----------- NET (LOSS) USED FOR COMPUTATION $ (887,000) $(1,014,000) $(2,366,000) $(2,669,000) ---------- ----------- ----------- ----------- ---------- ----------- ----------- ----------- Weighted average number of common shares outstanding 7,687,000 8,261,000 7,631,000 8,136,000 ---------- ----------- ----------- ----------- ---------- ----------- ----------- ----------- Net (loss) per common share $(0.12) $(0.12) $(0.31) $(0.33) ---------- ----------- ----------- ----------- ---------- ----------- ----------- -----------
11